Vitrolife
94.50 SEK
+2.66 %
Less than 1K followers
VITR
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+2.66 %
+5.76 %
-31.02 %
-30.57 %
-29.79 %
-44.08 %
-58.22 %
-62.94 %
+1,439.84 %
Vitrolife is an international group that provides medical devices and genetic services. The company develops and manufactures services and products for personalized genetic information as well as medical devices in the field of fertility. Vitrolife supports customers in their operations to improve patient outcomes from fertility treatments. Vitrolife's products and services are available globally. The company is headquartered in Gothenburg, Sweden.
Read moreMarket cap
12.8B SEK
Turnover
35.02M SEK
Revenue
3.44B
EBIT %
-140.55 %
P/E
-
Dividend yield-%
1.16 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
23/4
2026
Interim report Q1'26
6/5
2026
General meeting '26
7/5
2026
Annual dividend
All
Webcasts
Press releases
3rd party
ShowingAll content types
Redeye: Vitrolife (Q4 Review) - Excessive selloff improves risk/reward in the stock
Vitrolife, Audiocast, Q4'25
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
